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A 70-year-old woman, who has had a diagnosis of sarcoidosis since she was 38 years old, showed newly
appearing diffuse ground-glass opacities in the bilateral lung ﬁeld, and bilateral enlargement of the hilar
and mediastinal lymph nodes. Based on ﬁndings from bronchoalveolar lavage ﬂuid (BALF) and pathology
analysis, eosinophilic pneumonia accompanied by sarcoidosis was suspected. Both disease conditions
(sarcoidosis and BALF eosinophilia) worsened and improved simultaneously, and she showed two similar
episodes during the follow-up. This case prompted us to conduct a retrospective investigation of eosi-
nophil percentage in peripheral blood and BALF in 178 patients (excluding our patient) who had received
a diagnosis of sarcoidosis between 2000 and 2009 in our department. Among the 178 patients, the
highest eosinophil percentage in BALF was 2.6%; in contrast, peripheral blood eosinophilia was very
common. Thus we concluded that, for subjects with sarcoidosis, marked eosinophilia in BALF, as
observed in the case of this 70-year-old woman, was exceptional.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
According to previous reports, BALF eosinophilia in patients
with sarcoidosis is rare,1e3 and only three cases of sarcoidosis with
eosinophilia in BALF have been reported.4e6 Here we report an
interesting case of sarcoidosis with increased eosinophil percent-
age in peripheral blood and BALF. Of interest, both sarcoidosis and
eosinophilia worsened and improved simultaneously, and no pre-
vious reports have shown a simultaneous change in the severity of
these two disease conditions. Furthermore, we present the results
of a retrospective analysis of 178 patients (excluding our patient)
who had received a diagnosis of sarcoidosis in our department
between 2000 and 2009. Finally, we discuss the percentage of these
178 subjects that presented with an increase of eosinophils in pe-
ripheral blood and BALF.
2. Case report
A 70-year-old woman, who has had a diagnosis of sarcoidosis
since she was 38 years old, was admitted to our hospital in October; fax: þ81 11 706 7899.
onno).
-NC-ND license.2008. She had been followed without treatment after the initial
diagnosis, but she developed cough and dyspnea in September
2008. She had never smoked and had no apparent history of
exposure to allergens, had not been exposed to environmental
changes, and had not used new medicines or dietary supplements
for at least 6 months before admission. She had no history of any
allergic diseases, such as bronchial asthma, allergic rhinitis, or
atopic dermatitis. She lived in an urban area and had never traveled
to areas with a high prevalence of parasites. Laboratory data
revealed increases in peripheral eosinophil counts (10.0%, 869/mL),
total serum IgE levels [509.3 IU/L (normal: 0e295)], serum angio-
tensin converting enzyme (ACE) activity [33.5 IU/L (normal: 8.3e
21.5)], and soluble interleukin-2 receptor (sIL2R) [3932 U/mL
(normal: 0e459)] relative to data from three months before
(eosinophil: 5.0%, 330/mL, ACE: 23.2 IU/L). The results of IgE mul-
tiple antigen simultaneous tests revealed positive for Dermato-
phagoides farinae and negative for Aspergillus. Shewas also negative
for antineutrophil cytoplasmic antibodies to both myeloperoxidase
and proteinase 3. No evidence of parasites were found in stool
samples. High-resolution computed tomography (CT) revealed
diffuse ground-glass opacity in the bilateral middle and lower lobe,
and enlargement of bilateral hilar and mediastinal lymph nodes.
Analysis of BALF obtained from the right S4þ5 segment revealed
A. Takahashi et al. / Respiratory Medicine Case Reports 8 (2013) 43e4644elevated eosinophil (15.2%) and lymphocyte (51.2%) counts and
a high CD4/8 ratio (26.2), but no evidence of microbial culture. Lung
biopsy revealed inﬁltration of eosinophils in alveolar walls and
alveolar spaces (Fig 1a) with granulomatous tissue containing
multinucleated giant cells (Fig 1b), but no evidence of angiitis.
Transbronchial needle biopsy from the #7 lymph node also
revealed non-caseating epithelioid cell granuloma (Fig. 1c) with no
apparent pathogens, such as fungus or mycobacterium. Eosino-
philic pneumonia accompanied by sarcoidosis was suspected. Her
respiratory symptoms, the ground-glass opacities by chest X-ray
and peripheral eosinophilia, elevated serum ACE activity and sIL2R
remitted spontaneously without treatment within several months.
When her clinical course was evaluated retrospectively, it became
evident that she had had a similar episode in 2004; at that time, she
had developed a mild cough, ground-glass opacities in the lower
lobe of the left lung, peripheral eosinophilia, and elevated serumFig. 1. Pathological ﬁndings of a transbronchial lung biopsy specimen (a and b) and
transbronchial needle biopsy specimen from the #7 lymph node (c) (hematoxylin and
eosin stain, a 1000x, b 200x, c 40x). (a) Inﬁltration of eosinophils in alveolar walls and
alveolar spaces were observed. (b) Granulomatous tissue with multinucleated giant
cells was evident in lung parenchyma. (c) Non-caseating epithelioid cell granuloma
was evident.ACE activity (Fig. 2). All these symptoms remitted spontaneously
within several months without treatment.
3. Retrospective investigation of eosinophil percentage in
peripheral blood and BALF in patients with sarcoidosis in our
department
The case described above prompted us to conduct a retro-
spective study on eosinophil percentage in peripheral blood and
BALF in patients with sarcoidosis; 178 patients (excluding our pa-
tient) who had received a diagnosis of sarcoidosisdas per the ATS/
ERS/WASOG Statement on sarcoidosis7dbetween January 2000
and December 2009 at First Department of Medicine, Hokkaido
University Hospital were enrolled in this study. Among these 178
patients, the highest eosinophil percentage in BALF was 2.6%
(Table 1); in contrast, the eosinophil percentage in peripheral blood
was highly variable and reached a maximum of 22.0% in one case.
We categorized each subject into one of three groups (<4%, 4%e
10%, and 10%) according to the peripheral blood eosinophil per-
centage as described by Renston et al.8; we then evaluated the
presence of several allergic diseases on the basis of medical records
(Table 1). Although some patients with peripheral blood eosino-
philia had comorbidities, such as asthma or allergic rhinitis, others
did not have additional clinically apparent diseases. Percentage of
peripheral blood eosinophils of <4% or 4% were not associated
with the stage of sarcoidosis according to the results of the chi-
square test.
4. Discussion
Several studies have paid special attention to eosinophil per-
centage in BALF in patients with sarcoidosis, and eosinophils rep-
resented over 1% of all the inﬂammatory cells only in a few cases.1e3
Similarly, among the 178 patients examined in this retrospective
study, the highest eosinophil percentage in BALF was 2.6%. To the
best of our knowledge, only three sarcoidosis cases with elevated
eosinophil percentage in BALF have been reported,4e6 and in these
cases, the authors speculated the co-occurrence of chronic eosi-
nophilic pneumonia.
In contrast, Renston et al. reported that 41% of patients with
sarcoidosis showed an increase of peripheral blood eosinophil
percentage more than 4%.8 In the population used in this project,
peripheral blood eosinophilia, which was deﬁned as >4%, was
observed in 35.4% patients (63/178). Some patients had comor-
bidities (i.e. asthma, allergic rhinitis) that would potentially
cause eosinophilia. However, others did not show any evidence
of comorbidities on the basis of medical records. Considering
both the report by Renston et al. and the present ﬁndings, sar-
coidosis might be directly associated with peripheral eosino-
philia in some patients. That is, peripheral eosinophilia in
patients with sarcoidosis might not always indicate coexisting
allergic diseases.
Themechanism underlying the co-occurrence of sarcoidosis and
BALF eosinophilia is unclear. Tani et al. demonstrated that con-
centrations of IL-4, IL-5, and IFN-g were increased in BALF4 in their
case. Shijubo et al. discussed the possibility that factors related to
migration of both CD4-positive lymphocytes and eosinophils, such
as lymphocyte-chemoattractant factor (LCF) and IL-2,5 were
involved. In these two previous reports, there was no description of
the clinical course of concomitant sarcoidosis or BALF eosinophilia.
Our case of the 70-year-old woman is unique and interesting
because both sarcoidosis and BALF eosinophilia worsened and
improved simultaneously.
In summary, we report a case of sarcoidosis with a concomitant
increase in eosinophil percentage in peripheral blood and BALF;
Fig. 2. Clinical course from December 2002 to October 2010. Chest Xp and CT showed consolidation in left lung ﬁeld in 2004; additionally, serum ACE activity and percentage of
peripheral eosinophil were elevated. In 2008, ground-glass opacities were evident in the right lung ﬁled, and serum ACE activity and the percentage of peripheral eosinophil were
again elevated, but spontaneously remitted.
Table 1
Characteristics of 178 patients with sarcoidosis categorized according to percentage of peripheral (p) eosinophil.
All p eosinophil < 4% 4%  p eosinophil < 10% 10%  p eosinophil
Number 178 115 58 5
Male/female 62/116 37/78 24/34 1/4
Agea 56 (17e79) 60 (17e79) 50 (20e75) 61 (24e76)
Smoking (No/Ex/Current) 80/40/58 53/25/37 24/14/20 3/1/1
Stage (0/I/II/III) 31/88/45/14 23/54/29/9 8/30/16/4 0/4/0/1
ACE (IU/l)a 23.6 (0.9e48.3) 23.6 (4.1e48.3) 24.2 (0.9e42.2) 29.8 (22.1e36.4)
BAL
Total cells (104/ml BALF)a 17.0 (2.2e92.2) 17.9 (2.2e89.8) 17.4 (4.3e92.2) 37.6 (17e51.5)
Macrophage (%)a 64.6 (8.2e96.8) 65.3 (8.2e96.4) 64.6 (22.8e96.8) 70.3 (51.9e91.8)
Lymphocytes (%)a 34.3 (2.8e92.4) 33.6 (3.6e92.4) 34.8 (2.8e76.3) 38.3 (5.6e47.1)
Neutrophil (%)a 0.2 (0e7.0) 0.2 (0e7.0) 0.2 (0e2.0) 0 (0e1.0)
Eosinophil (%)a 0 (0e2.6) 0 (0e2.4) 0 (0e2.0) 1.3 (0e2.6)
CD4/CD8a 4.59 (0.72e30.2) 4.20 (0.72e15.5) 5.17(0.79e30.2) 5.18 (4.01e16.1)
Peripheral eosinophil (/ml)a 148.8(0e1034) 92.8(0e277)b 250 (146e795) 589 (332e1034)
Peripheral eosinophil (%)a 2.8 (0e22.0) 2.0 (0e3.9)b 5.0 (4.0e9.7) 12.0 (10.7e22.0)
Asthma (%) 6 (3.4) 2 (1.7) 1 (0.2) 3 (60.0)
Allergic rhinitis (%) 7 (3.9) 5 (4.3) 2 (3.4) 0 (0)
Atopic dermatitis (%) 1 (0.5) 1 (0.8) 0 (0) 0 (0)
Drug allergy (%) 14 (7.9) 10 (8.7) 2 (3.4) 2 (40.0)
Food allergy (%) 4 (2.2) 2 (1.7) 2 (3.4) 0 (0)
a Median (range).
b p < 0.05 (compared with p eosinophil 4%).
A. Takahashi et al. / Respiratory Medicine Case Reports 8 (2013) 43e46 45both disease conditions worsened and improved simultaneously. In
addition, as a result of a retrospective investigation of eosinophil
percentage in 178 patients with sarcoidosis in our department, we
concluded that BALF eosinophilia in patients with sarcoidosis is
extremely rare, whereas the coexistence of sarcoidosis and pe-
ripheral eosinophilia is very common.Disclosure of conﬂict of interest
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